Hunan Hansen Pharmaceutical Co., Ltd.

002412

CNE100000PK2

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
6.03 ^CNY	+0.50%		-0.99%	-11.06%

Apr. 26	Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 26	Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020

April 29, 2021 at 03:42 pm EDT

Hunan Hansen Pharmaceutical Co., Ltd. approved the cash dividend of CNY 0.00000000 per 10 shares (tax included), at the Annual General Meeting of 2020 held on 29 April 2021.

Latest news about Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Hansen Pharmaceutical Gets Nod to Amend Information for Isoniazid Tablets	Nov. 09	MT
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Hunan Hansen Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023	23-06-14	CI
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-24	CI
Hunan Hansen Pharmaceutical Co., Ltd. Announces Board Appointments	23-05-24	CI
Hansen Pharma's Iohexol Injection Passes Drug Regulator's Evaluation	23-05-09	MT
Hunan Hansen Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	23-05-04	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Hansen Health Industry Co., Ltd. announced that it expects to receive CNY 40 million in funding from Hunan Hansen Pharmaceutical Co., Ltd.	22-11-10	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020	21-04-29	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Hansen Health Industry Co., Ltd. announced that it expects to receive CNY 138 million in funding from Hunan Hansen Pharmaceutical Co., Ltd.	21-01-13	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-26	CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-20	CI
Hunan Hansen Pharmaceutical Co., Ltd. Announces to Implement Final Cash Distribution Plan for 2019, Payable on 24 June 2020	20-06-18	CI

Chart Hunan Hansen Pharmaceutical Co., Ltd.

Duration

Period

Chart Hunan Hansen Pharmaceutical Co., Ltd.

More charts

Hunan Hansen Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of traditional Chinese medicine preparations, chemical medicine and medical preparations. The Companyâs main products include Simotang oral liquid, used for abdominal distention and phlegmatic abdominalgia; Yushangling capsules, used for injuries from falls; Yinxingye capsules, used for stroke and chest distress, as well as Suoquan capsules, used for kidney deficiency, among others. The Company mainly distributes its products in domestic markets.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUNAN HANSEN PHARMACEUTICAL CO., LTD.	-11.06%	420M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals